These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 1425220)
21. Peri-operative anticoagulant therapy--the case for an uninterrupted dose-adjusted warfarin regimen in the high-risk patient. Franz RC S Afr J Surg; 2006 Aug; 44(3):84, 86. PubMed ID: 16958233 [No Abstract] [Full Text] [Related]
22. Anticoagulants in myocardial infarction. Med Lett Drugs Ther; 1974 Feb; 16(4):17-9. PubMed ID: 4815687 [No Abstract] [Full Text] [Related]
23. Anticoagulation quality and the risk of recurrence of venous thromboembolism. Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D Thromb Haemost; 2007 Nov; 98(5):1148-50. PubMed ID: 18000626 [No Abstract] [Full Text] [Related]
24. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? Caine GJ; Lip GY Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973 [No Abstract] [Full Text] [Related]
25. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation. Marchant BG; Timmis AD Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785 [TBL] [Abstract][Full Text] [Related]
26. Traveling as a risk factor for venous thromboembolic disease. Ercegovac UC; Metcalfe TL; Penn BH; Smith KM; Elmore JG Respir Care; 2006 Oct; 51(10):1177-80. PubMed ID: 17044147 [No Abstract] [Full Text] [Related]
28. Hazards of subdural and epidural anesthesia during anticoagulant therapy: a case report and review. DeAngelis J Anesth Analg; 1972; 51(5):676-9. PubMed ID: 4672158 [No Abstract] [Full Text] [Related]
29. Therapy with anticoagulant drugs. O'Reilly RA Ration Drug Ther; 1974 Jun; 8(6):1-7. PubMed ID: 4845147 [No Abstract] [Full Text] [Related]
33. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757 [TBL] [Abstract][Full Text] [Related]
34. Total resistance to oral anticoagulants (nicoumalone and warfarin). Danesi MA Br J Clin Pract; 1980 Feb; 34(2):55, 64. PubMed ID: 7387825 [No Abstract] [Full Text] [Related]
35. Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy. Vadher B; Patterson DL; Leaning M Br J Clin Pharmacol; 1999 Jul; 48(1):63-70. PubMed ID: 10383562 [TBL] [Abstract][Full Text] [Related]
36. How to anticoagulate. Drug Ther Bull; 1992 Sep; 30(20):77-80. PubMed ID: 1425220 [No Abstract] [Full Text] [Related]
37. Successful use of heparin and warfarin in the treatment of cholesterol crystal embolization. Wakabayashi T; Yoshizawa Y; Kawana S J Dermatol; 2008 Feb; 35(2):111-4. PubMed ID: 18271808 [TBL] [Abstract][Full Text] [Related]